RxDoctor Payments Data

Sreekanth Karanam, MD

Cardiovascular Disease · Springfield, ORNPI 1912978438

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (41.8%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 64.7% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $12,648 and has fallen 78.6% since, to $2,708 in 2025. Among cardiovascular disease clinicians in OR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$36,519in general payments, 2019–2025

Across 358 payments — averaging $102.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$24K
  • Medtronic$6K
  • Biotronik Inc.$3K
  • Abbott$3K
  • Acutus Medical, Inc.$417
  • Cook Medical LLC$87
  • plus $103 from 2 others

What the payments were for

  • Speaking & faculty fees$15,25042%
  • Travel & lodging$10,84630%
  • Food & beverage$10,42429%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific236$23,618
Medtronic(2 entities)70$6,209
Biotronik Inc.18$3,046
Abbott22$3,041
Acutus Medical, Inc.8$417
Cook Medical LLC1$87
Atricure, Inc.2$78
Cardiva Medical, Inc.1$25

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$36,519 in reported general payments places this provider in the 90th percentile of 198 cardiovascular disease providers in Oregon.

See all cardiovascular disease providers in Oregon

Medicare billing

Part B allowed, 2024
$148,006
Medicare patients
799
Services billed
1,609

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban139$153,314
XareltoRivaroxaban28$38,358
EntrestoSacubitril/Valsartan23$20,814
Flecainide Acetate62$2,637
Metoprolol Succinate112$1,844
Diltiazem 24hr Er (Cd)Diltiazem Hcl56$1,589
SotalolSotalol Hcl57$1,396
Amiodarone Hcl65$1,003
Digoxin11$540
ClopidogrelClopidogrel Bisulfate21$395
Cartia XtDiltiazem Hcl15$325
Potassium Chloride15$271
Carvedilol15$162
Amlodipine Besylate17$159
Metoprolol Tartrate14$92

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Springfield

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →